Sophia Salmon MRCVS from Central CPD said: "All of the major corporate chains in the UK now deliver a significant proportion of their clinical and non-clinical staff training via online learning platforms. These systems form an important part of professional development, training standardisation and even performance evaluation.
"However, learning platforms can be expensive to procure and develop, as well as being time-consuming to maintain, and therefore may not be viable for smaller businesses."
Central CPD has used its experience providing online learning to several of the UK’s major corporate veterinary groups to create 'Central CPD On-Demand', which features over 1500 clinical and non-clinical CPD videos for vets, nurses, managers and receptionists.
There's a new practice subscription package which, developed with whole-team learning in mind, costs £2000 per year for up to twenty people (veterinary surgeons, nurses or management staff).
Central CPD says the new package allows individuals and practices to set their own learning plan for the year, and for mentors to build and supervise training programmes for other staff members.
Practices can add their own content, such as policy documents, in order to assist with the delivery of compulsory elements of staff training.
Central CPD says its service is a fraction of the cost of procuring and populating an off-the-shelf learning platform, and the company is staffed by vets and vet nurses who are available to provide one-to-one advice and support to help practices set up their team’s platform and get the most out of the system.
For more information, visit: https://centralcpd.co.uk/
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
The British Veterinary Association has expressed disappointment at the Government's decision to introduce a licensing regime rather than impose an outright ban on the use of wild animals in travelling circuses.
Defra Secretary of State Caroline Spelman announced today that a ban on circus animals could not be introduced in the UK now because a ban introduced in Austria is currently being challenged under European law. In a written ministerial statement she said that the Government will now draw up standards for a new licensing regime.
BVA President Harvey Locke said: "The BVA strongly supported a ban because we believe the welfare of these animals is emblematic of the way we treat all animals under the care of humans.
"The welfare needs of non-domesticated, wild animals cannot be met within the environment of a travelling circus; especially in terms of accommodation and the ability to express normal behaviour. A licensing scheme will not address these issues."
Together with the RPSCA, Captive Animals' Protection Society and the Born Free Foundation, the BVA has wholeheartedly supported The Independent's campaign to ban wild animals in circuses. Over 15,000 people have signed The Independent's online petition, which is still open. Mr Locke will be joining representatives from these groups to present the petition to Downing Street next week.
Mr Locke added: "Although it only affects a small number of animals at present there is no guarantee that the number of wild animals in circuses won't increase in the future and, despite the best intentions, the needs of these animals cannot be met adequately by the environmental conditions of a travelling circus.
"As soon as the Austria situation is resolved, we would urge the Government to reconsider and take action to prohibit the exploitation of these majestic animals whose existence in the confines of a circus is solely to entertain people."
Seven graduands from The University of Nottingham's School of Veterinary Medicine and Science have become the first from the new school to become members of the Royal College of Veterinary Surgeons.
Nottingham is the first new veterinary school in the UK for over 50 years, and the process to recognise its degree for the purposes of RCVS membership is currently in its final stages. Following a visitation and audit process, RCVS Council unanimously recommended the degree's approval to the Privy Council, where the final decision lies.
Generally, veterinary graduates become RCVS members - which they need to be in order to practise in the UK - at a ceremony on the day of their graduation. However, sometimes they wish to start work before graduation and can therefore apply to register as graduands, as in this case.
Although formal Privy Council approval of the Nottingham degree is still awaited, RCVS external examiners have overseen the School's final exams during the last year of the course to ensure that they meet the required standards.
The Nottingham graduation ceremony will take place on 22 July, when a further 77 students will graduate, and those wishing to practise in the UK will become members of the College.
The RCVS 2010 Survey of the Veterinary and Veterinary Nursing Professions indicated that, on average, new graduates took one month to find work on graduating, with 63% going straight into clinical practice.
In the series of 9 short videos, BCF's in-house vet, Kimberly Palgrave, demonstrates how to perform a basic abdominal ultrasound examination in small animal patients.
The videos, which were produced in collaboration with The Royal (Dick) School of Veterinary Studies, also cover how to alter the controls on your ultrasound machine to get the most of your equipment.
Kimberly said: "I am really passionate about encouraging as many vets using ultrasound in their daily routine as a diagnostic tool. My aim for these videos is to give vets in practice a resource to develop their ultrasound skills. We hope you enjoy the videos and we are already busy developing further videos."
To see the videos visit the ultrasound gallery.
www.bcftechnology.com / www.facebook.com/bcftechnology.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Elanco Companion Animal Health has launched a dermatology e-newsletter called Under The Skin, designed to help veterinary professionals stay informed and up to date on a wide range of skin conditions.
Featuring a guest editor for each edition, experts will review interesting case studies and research papers and discuss diagnosis and treatment options.
The launch issue focuses on otitis and is edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology.
Topics include a review of a clinical case - Pseudomonas otitis in a Cocker Spaniel called Rosie, a video otoscopy before and during Rosie's ear flush, information on antimicrobial resistance (AMR), a discussion on whether to carry out in-house ear cytology, product information on Surolan and a review of the causes of otitis.
The newsletter also features hints and tips on how to prevent contamination of ear medication/ear cleaners, the importance of marking products with expiry dates, information on applying topical ear cleaners/ear medication and owner education on how to apply the medication.
To receive priority notification of future editions of Elanco's 'Under The Skin' e-newsletter, register at www.thewebinarvet.com/elanco
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
Five graduates from St George's University School of Veterinary Medicine (SGUSVM), in the Caribbean island of Grenada, have passed the Statutory Membership Examination of the UK's Royal College of Veterinary Surgeons.
According to the University, SGUSVM graduates have traditionally demonstrated impressive pass rates on this rigorous exam, but this year's 100% pass rate by SGU students - compared with an overall 44% pass rate for candidates overall - is an exceptional result for SGU students, and only the second time it has been achieved in the school's history.
In order to practice veterinary surgery in the UK, all graduates with foreign or Commonwealth qualifications must pass the RCVS examination. The exam consists of two days of written papers, followed by clinical, oral and practical exams at a UK veterinary medical school. Thirty-five St George's graduates have passed into the RCVS since the School's inception in 1999.
The RCVS sets no quota for this Statutory Membership Examination, meaning those who meet the standards will pass, regardless of the number of candidates sitting the exam.
Austin Kirwan, St George's Associate Dean of UK and Ireland Clinical Affairs stated: "St George's School of Veterinary Medicine once again produces an excellent set of results with a 100 percent pass rate for the Royal College of Veterinary Surgeons Statutory Membership Examination for those SGU students who sat the examination. This is a credit to the school in the quality of education it provides, but also an indication of the calibre of person SGU attracts in its student cohort - outstanding success abounds by thinking beyond."
Presenting the graduates with a membership certificate at the Ceremony of Admissions at Belgravia House in London, RCVS President Dr Jerry Davies said: "I was delighted to welcome so many of this year's successful candidates to the College. Whether newly graduated or long qualified elsewhere, all of those registering today have succeeded in meeting the educational and professional requirements that enable them to call themselves veterinary surgeons and to practise in the UK."
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Fort Dodge Animal Health has announced that its Duvaxyn WNV vaccine against West Nile Virus (WNV) is now available in the UK, following its licensing through the European Medicines Agency (EMEA).
Duvaxyn WNV is the first vaccine available in Europe to protect horses against this emerging disease threat. 288 horses and two people in Italy were found to be infected with WNV during the outbreak that hit northern Italy in late 2008 where it is now considered endemic. The disease is endemic in all areas of North America where it has claimed the lives of both horses and humans.
West Nile Virus is caused by a highly contagious flavivirus, which is transmitted by mosquitoes, primarily of the Culex species. The natural hosts of West Nile virus are birds, with migratory birds from Africa carrying the disease. Mosquitoes become infected after taking a blood meal from infected birds and then may transmit the disease to horses and even humans. While horses are 'dead end hosts,' the consequences can be severe as the virus causes encephalitis or meningitis. Mortality rates among horses which develop neurological signs are high and there is no palliative cure for the disease. Treatment is limited to symptomatic relief which can be long and expensive.
Sabrina Jordan, UK Business Manager for Equine Vaccines at Fort Dodge said: "WNV is an increasing threat to the equestrian sector in the UK and is a particular challenge for owners who transport their horses around the world.
"The fact that a vaccine is now available will undoubtedly offer peace of mind to the equestrian community. They can be reassured that horses in the UK can now be vaccinated against WNV with a vaccine that has already been shown to be highly effective in protecting horses in America.
"With any vaccine, a record that a horse has been vaccinated with Duvaxyn WNV should be recorded in its horse passport. By presenting this vaccine in pre-filled syringes with Infovax-ID labels, we've aimed to make both the administration and record keeping of Duvaxyn WNV as convenient as possible.
"To build understanding of this potentially fatal disease threat, we are continuing to work with governments and authorities at a national and European level, as well as working in partnership with the UK's veterinary community to ensure that owners are fully informed about the risk WNV poses and of the benefits of vaccination."
Norbrook has launched palatable pork liver flavoured Carprieve tablets to help make dosing dogs a stress-free experience for dog and owner.
Offering Cox-2 preferential pain release, Carprieve Flavoured Tablets are indicated for chronic inflammation, such as degenerative joint disease in dogs, as well as post-operative pain management. According to Norbrook, tests have shown 75 per cent of dogs will take them voluntarily.
Sascha van Helvoort MRCVS, international veterinary adviser for Norbrook Laboratories, said: "Palatability is an important consideration for owners, especially for dogs with chronic inflammation, who often need regular tablets.
"Success is often hit-and-miss, with dogs leaving tablets given in food or spitting them out. This led to us testing pork liver tasting carprofen tablets on dogs who needed treatment, and the vast majority ate them from a bowl. This means vets can prescribe them with all confidence that the dogs will get their medicine.
Sascha added: "Studies undertaken by Norbrook covered a wide range of breeds, and included dogs from one year old to 14. In addition, the majority preferred the Pork liver flavour to top brand 'palatable' tablets.
"Getting the dosage right is also easy. That's why we decided to introduce our Carprieve Flavoured Tablets in blister packs rather than in tubs to aid dosage administration."
For more information, visit: http://www.norbrook.co.uk
The 2014 Vet Charity Challenge is now open and teams can register via the website at www.vetcharitychallenge.co.uk.
The event takes place on Saturday 27th September at St Francis School, Pewsey, near Marlborough in Wiltshire. The day consists of teams of four taking part in walking/running, cycling and kayaking, some orienteering as well as some mental and physical tasks. All the time trying to gain as many points as possible. Last year the event raised over £50,000 for the three selected animal based charities. In 2014 the charities being supported are Hearing Dogs for Deaf People, SPANA and Cats Protection.
Gavin Mitchell from BCF Technology said: "Interest in the Vet Charity Challenge was so great last year that we had teams on a waiting list. To ensure your team gets a place we highly recommend that you register your team on the website early. We will be entering five teams from BCF this year, such is the demand from our own staff."
Andrew Groom from Kruuse added: "The Vet Charity Challenge is a great event. Helping you build your team within your veterinary practice, acting as a goal for those that want to become a bit fitter, encouraging training together over the summer months. It is great fun and also raises considerable sums of money for some really deserving charities. Don't delay, get your teams together and register now on the website. The event is designed for all levels of fitness. It is not the fittest team that wins, but the team that works the best together."
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his practice’s equipment and facilities in working order such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Monday 15 May was Mr Seymour-Hamilton’s fifth application for restoration, with previous applications being submitted but refused in July 1995, June 2010, January 2015 and March 2016. However, as the Committee made its decision on the merits of the case before it, those previous applications were not considered as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research, citing his treatment of one of his dogs as evidence.
The Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient; and his lack of evidence of public support for him or his work.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has very great concerns about the future of the welfare of animals in the event of the applicant being permitted to have his name restored to the Register. He has made it clear that whilst he has no intention to return to routine veterinary general practice, he would intend to treat animals and to continue his research using animals. The Committee observes that were he to be restored to the Register, there would be no power to prevent the applicant practising as a veterinary surgeon in any way he may choose."
He added: "The applicant has now been off the Register for nearly 23 years. It will be apparent to anyone that the veterinary profession today is in many respects different from what it was 23 years ago, (eg: in terms of medical understanding and its own regulation). The Committee is far from persuaded that the passage of 23 years has not had a negative impact on the applicant’s ability to practise safely and competently as a veterinary surgeon at this present time."
The BSAVA Library Collection, which is freely available until the end of June 2020, includes resources relating to total intravenous anaesthesia (TIVA) and anaesthetic monitoring in addition to a new guidance document on the administration of anaesthetics during the pandemic, which has been endorsed by the Association of Veterinary Anaesthetists (AVA).
Kerry Woodhouse, author of the guidance document, said: “In line with RCVS recommendations to promote safe practice and social distancing, anaesthesia for routine procedures should be stopped during the current restrictions relating to the COVID-19 pandemic. There will however remain a need for anaesthetics for emergency and urgent procedures on welfare grounds. This guidance document provides practical information on administering anaesthesia while conserving oxygen supplies."
BSAVA President, Sue Paterson added: “The potential prioritisation of oxygen cylinders into human medicines means that we must be ready and able to revert back to using some more basic anaesthetic techniques. BSAVA is pleased to be able to support the profession during these challenging times through the provision of up-to-date guidance and resources to address these concerns.”
The new Anaesthesia Resources collection can be found here: https://www.bsavalibrary.com/content/update
The Association is also reassuring the profession that there is no indication of a shortage of medical gases.
In preparation for an escalation of coronavirus cases, BOC has been building stocks of medical gases to ensure its supply chain is in the best position to respond to customer requirements.
BOC has also implemented a ‘Full for Empty’ supply of all medical cylinder gases and customers with medical oxygen are being encouraged to manage their cylinders in an effective manner and ensure that empty cylinders are available promptly for collection. The company has also increased the frequency of deliveries and collections to help with cylinder turnover.
Customers are being asked to be vigilant and ensure that medical gas cylinders are kept as secure as possible to deter potential misuse or theft.
BSAVA understands that if a practice is closed for the foreseeable future, BOC will collect cylinders free of charge.
For further information, call BOC’s Customer Information Centre on 0800 111 333 or visit https://www.boconline.co.uk/shop/en/uk/customer-information
For more BSAVA resources relating to coronavirus, visit https://www.bsava.com/adviceforCOVID19
VetYogi’s new ‘VetYogi Collective’ offers an on-demand online hub of yoga, mental health and wellbeing sessions designed to meet the individual needs of vets, RVNs, practice managers, receptionists, students and paraprofessionals.
Subscription includes a monthly live yoga session and access to a library of content which includes yoga sessions lasting from minutes to over an hour.
There are also videos, and advice on guided meditation to help support wellbeing and manage stress.
Chloe says: “It’s important that everyone who has a need, has access to the type of wellbeing tools that they respond best to, so we have developed self-care sessions for all roles in the profession.
"If you have had a hard day or a stiff neck from working in theatre for hours, or are just feeling tense and unable to switch off, you need help there and then.
"The VetYogi Collective provides that support around the clock which we simply couldn’t deliver any other way.”
Individual subscriptions cost £12 per month.
Practices signing up their team are offered preferential rates and can use the VetYogi Collective badge on their materials to signal their commitment to supporting wellbeing.
collective.vetyogi.com
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
The judging panel, comprising BVA President Anna Judson, RCVS President Sue Paterson, National Veterinary Lead Ruminant and Equine at Zoetis UK Ally Ward, and last year’s award winner Hannah Hunt, selected the finalists based on their inspirational work which includes supporting clients and colleagues, providing outstanding and consistent care for patients, inspiring others and giving back to their community, championing causes in the profession and going above and beyond the normal call of duty.
Rebecca, who graduated from Bristol in 2015, was nominated for her work co-founding Veterinary Education Malawi, an animal welfare charity which provides free veterinary services to low-income communities and educational support both to the para vets in the country and to the Lilongwe University of Agriculture and Natural Resources (LUANAR), its only vet school.
Henry, a commercial poultry and gamebird vet, was nominated for his work tackling outbreaks of avian influenza and encouraging other young vets to take up roles in the poultry industry.
Henry is also a European College of Poultry Veterinary Science resident, mental health first aider and trustee of regional rural mental health charity You Are Not Alone (YANA), co-lead of his practice green group, and deputy rotation lead for the new RVC poultry rotation, which takes its first students in 2024.
Camilla is an equine vet who was nominated for her dedication to promoting the veterinary profession, equine welfare, and for her work setting up the ambulatory equine practice, Perth Equine Vets.
A Glasgow 2015 graduate, Camilla set up Perth Equine Vets in 2020 growing it into the three vet practice it is today.
She organises frequent events, most recently a “get into vet school” day for upcoming vet students, which saw more than 40 potential senior school pupils attend, alongside educational demos for owners to increase their own knowledge. She also regularly creates blogs and videos on the practice social media accounts which helps horse owners learn essential skills.
BVA President Anna Judson said: “BVA’s Young Vet of the Year showcases exceptional vets from across the UK making an invaluable contribution to the profession.
"This year we have been blown away by all the incredible nominations, but these three young vets really stood out for their contribution to their fields and their commitment to their unique causes and passions.
"Congratulations to all of the finalists, you are a credit to the veterinary profession and we know you have bright futures ahead of you.”
The winner of BVA Young Vet of the Year will be announced at BVA's Gala Dinner taking place at the London Vet Show on 16th November.
Photo: R-L, Camilla Church, Henry Lamb and Rebecca Hampson
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.
Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.
Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.
In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.
Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.
"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”
Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”
The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279
Reference
Photo: Professor Ian Ramsey
Andra-Elena Enache and Savina Gogova join the head of service Richard Everson, an RCVS and European Recognised Specialist, to form one of the strongest ophthalmology teams in the UK.
Richard said: “It is fabulous that Andra and Savina were both successful in their specialist examinations.
“Of course, we already knew their expertise but passing the examination requires not just an unparalleled knowledge of their subject but also the constitution that allows them to prove their knowledge, skills and professionalism in the crucible of the examination environment.
“For both Andra and Savina to pass at the first time of asking is remarkable and just confirms their brilliance. It’s also a big boost for NDSR.
“Having three internationally-recognised specialists in ophthalmology in one hospital makes the service so much more resilient; for example, we will never have to close due to annual leave or lecturing commitments.
“This strength in depth means we really can offer the best possible service to our referring vets and poorly pets.”
For more information, visit: www.ndsr.co.uk.
The new guide, developed in association with Vets Digital, is the latest addition to BVA’s ‘Respect your vet team – end abuse’ campaign, which aims to support vets and veterinary workplaces who experience abuse from animal owners either in person or online.
It will be added to the Respect Your Vet Team toolkit, which offers a range of resources designed to help protect staff and limit the frequency and impact of abuse from clients.
The resources include practical tips on how to protect staff from online abuse, downloadable posters encouraging respectful behaviour from clients and a series of blogs exploring the issues.
BVA President Malcolm Morley said: “The vast majority of clients are hugely appreciative of the care they receive from their vet teams, resulting in thousands of positive reviews every year.
"While we recognise not every client will have a positive experience and may wish to provide critical feedback, a small number are posting deliberately abusive or unfair reviews.
"This is unacceptable and can have a hugely negative impact on individual veterinary professionals and the wider team.
"Protecting the wellbeing of veterinary teams remains a top priority for BVA and this new resource will help vet teams to take practical steps to limit the impact of this type of abuse.”
https://www.bva.co.uk/resources-support/misc-resources/how-to-manage-unfair-and-abusive-reviews-online
The researchers’ objective was to determine whether dogs with intracranial space occupying lesions (iSOLs) on MRI, or MRI-determined indicators of intracranial hypertension (ICH) had higher sedation scores with a more rapid onset of recumbency after the administration of IV butorphanol than dogs without intracranial disease.
They hypothesised that 0.2 mg kg-1 of butorphanol administered intravenously would result in statistically significantly higher sedation scores and quicker onset of recumbency in dogs with MRI-iSOL and MRI-ICH.
For the observational study: 'The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension', 53 dogs presented for a brain MRI.
Each dog was sedated with 0.2 mg kg-1butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after administration for 15 minutes using a modified sedation scale.
The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand.
Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5 respectively) 15 minutes after butorphanol administration (T15, p < 0.01).
A greater number of dogs with MRI-ICH achieved recumbency (n = 9/10; 90%) than those without MRI-ICH (n = 20/43; 46.5%; p = 0.01).
Emma Sansby, Resident in Anaesthesia and Analgesia at Lumbry Park Veterinary Specialists, who led the research, said: “When intracranial disease is suspected, the administration of butorphanol as a premedicant for anaesthesia could be used to predict the presence of MRI-iSOL and MRI-ICH.
"If a dog becomes recumbent or has a sedation score of more than 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH – so as not to increase intracranial pressure.
“These adaptations include but are not limited to; adequate preoxygenation - to prevent hypoxaemia and elevation of the head to no more than 30 degrees; preventing increases in central venous pressure - by avoiding jugular compression and avoiding excessive intraabdominal and intrathoracic pressure; and a smooth anaesthetic induction - ensuring an adequate depth of anaesthesia prior to tracheal intubation to prevent the cough reflex and judicious mechanical ventilation to enable a low-normal end-tidal carbon dioxide.”
Photo: www.depositphotos.com
In its updated position statement, the association emphasises its support of current UK legislation and says it would like to see improved implementation of current laws, in particular when informed by an evidence-based welfare outcomes approach.
The BVA also recommends that any proposals to improve welfare during transport should embrace all forms of transport and include welfare issues before, during and after movement. This, it says, would help ensure that a well-defined set of animal welfare standards are met for the entirety of any journey.
The BVA recommends that animals are slaughtered as close to the point of production as possible and supports the exploration of further opportunities which would assist this. It recognises that transportation of live animals can be unavoidable in some situations – for example, journeys between the Scottish Islands and Highlands – but says that no animal should be exported to a destination with unknown welfare standards, to one using systems currently banned in the UK or to a country where it would be slaughtered without stunning.
BVA President Simon Doherty said: "Any kind of movement has the potential to impact on an animal’s health and welfare. Ideally, we’d like to see livestock slaughtered close to the point of production, as long as all legislative health and welfare standards can be maintained. However, we recognise the high standards of welfare in the UK and support better implementation of current legislation.
"We have taken care to reiterate that any improvements made to live animal transport should consider welfare issues before, during and after movement so that a more complete approach is taken on this issue.
"We recognise that journey length is not the only influencer of welfare conditions for animals, and transport needs to be looked at as a whole rather than focusing on single factors. The most important thing for Government to do is to consider the evidence base when it weighs up options for making improvements."
CEVA Animal Health and the University of Lincoln have presented three distance learning students on the university's pheromone therapy course with awards in recognition of their research into the benefits of pheromone therapy in combating behavioural problems in pets.
Veterinary nurse, Mandy Davis RVN, won first place and was presented with a cheque for £1,000 for her evaluation of the use of rabbit appeasing pheromones in a pet demonstrating fearful and aggressive behaviour towards its owner.
Second place and a cheque for £500 went to pet behaviourist and VetSurgeon member, Dr Carri Westgarth BSc(Hons) PhD from the University of Liverpool, for her case which reported on the use of D.A.P.® and clomipromine in a separation-related problem in a dog.
Third place and a cheque for £250 was awarded to veterinary surgeon, Graeme Buchan BVMS MRCVS, from Blackness Veterinary Centre in Dundee for his study into the use of a D.A.P.® Collar in the management of disruptive stress in the home.
"More and more pets are referred to animal behaviour experts each year and pheromone therapy is increasingly being used to help pets overcome behavioural issues such as aggression and separation anxiety," said Professor Daniel Mills, recognised specialist in veterinary behavioural medicine, at the University of Lincoln. "The students' case histories demonstrated their understanding of the benefits of pheromone therapy and how products that mimic the effects of naturally occurring pheromones can improve both the health and welfare of stressed pets. Many of the reports were of a very high standard, and showed a good understanding of the science behind the practice, which is so important for effective use."
The University of Lincoln launched the country's first accredited course in pheromone therapy in 2007 to help increase the veterinary profession's understanding of stress and its potential to trigger behavioural issues in pets. The distance learning course, which is supported by CEVA Animal Health, is aimed at veterinary surgeons, veterinary nurses and behaviourists and comprises 12 audio visual tutorials covering pheromone therapy and its applications in companion animals which can be undertaken at a pace to suit individual students.
Lucy Brett, product manager at CEVA Animal Health said: "The pheromone therapy course is a must for veterinary professionals wishing to learn more about behavioural problems in pets, including the stress triggers that can lead to disruptive and undesirable behaviour and the benefits of synthetic copies of natural pheromones in overcoming these issues."
The deadline for applications for the University of Lincoln's next Pheromone Therapy Course, which starts in February 2009, is 16 December 2008. For further information, please contact the University of Lincoln on 01522 882000 or visit www.lincoln.ac.uk.
The Veterinary Wound Healing Association (VWHA) has become the third veterinary association to make a new home on VetSurgeon.org.
VWHA President Jacintha Wilmink said: "We're very excited about joining VetSurgeon.org and how it will allow our members to connect with each other and share information quicker and more easily than ever before".
In common with the other associations, the VWHA is making its content available for all VetSurgeon members to access, however only VWHA members can submit cases to its section for discussion, or participate in the VWHA forum. Jacintha added: "We hope that the cases and discussions in our section of the site will be of value to all practitioners, and that many more of you will want to join the association and participate".
Information about the benefits of joining the VWHA is available here.